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Abstract
Introduction The purpose of this study was to evaluate sedation
practice in UK intensive care units (ICUs), particularly the
implementation of daily sedation holding, written sedation
guidelines, sedation scoring tools and choice of agents.
Methods A national postal survey was conducted in all UK
ICUs.
Results A total of 192 responses out of 302 addressed units
were received (63.5%). Of the responding ICUs, 88% used a
sedation scoring tool, most frequently the Ramsey Sedation
Scale score (66.4%). The majority of units have a written
sedation guideline (80%), and 78% state that daily sedation
holding is practiced. A wide variety of sedating agents is used,
with the choice of agent largely determined by the duration of
action rather than cost. The most frequently used agents were
propofol and alfentanil for short-term sedation; propofol,
midazolam and morphine for longer sedation; and propofol for
weaning purposes.
Conclusions Most UK ICUs use a sedation guideline and
sedation scoring tool. The concept of sedation holding has been
implemented in the majority of units, and most ICUs have a
written sedation guideline.
Introduction
Patients requiring mechanical ventilation in the intensive care
unit (ICU) usually require a sedating agent [1]. Sedation
reduces the negative physiological effects of the stress
response to mechanical ventilation [2,3] and may reduce the
psychological issues patients may face after critical illness [4].
However, excessive sedation may be harmful. Over-sedation
can contribute to hypotension, venous thrombosis, prolonged
ventilation, an increased risk for pneumonia and a prolonged
stay in the ICU, with an increasing burden on staff, bed availa-
bility and associated costs [5,6].
Recent evidence indicates that the choice of sedating agents,
frequency of administration and regular assessment of seda-
tion contribute to patient outcomes [7-9]. Kress and cowork-
ers [7], in 2000, demonstrated that daily interruption of
sedation reduced ventilation duration, ICU length of stay, com-
plications such as venous thromboembolic disease, upper
gastrointestinal bleeding and bacteraemia, and the incidence
of post-traumatic stress disorder [10,11].
There have been a number of systematic reviews of sedation
practice in the ICU and subsequent evidence-based clinical
practice guidelines for sedation [12-16]. However, uptake of
these evidence-based guidelines is variable. Sedation surveys
in a range of countries have demonstrated different practices
in the management of sedation [17-21]. The last survey of
sedation practice in UK ICUs was published in 2000 [22],
before the concept of daily sedation holding was published.
The rate of implementation of current sedation guidelines in
UK ICUs is unknown.
This UK national survey was performed to assess the impact
of published trials and guidelines on ICU sedation practice
since 2000.
Materials and methods
A tick-box questionnaire was developed to survey sedation
practice [see Additional data file 1]. The questionnaire was
sent to all UK ICUs. The list of units was obtained from the
Intensive Care National Audit & Research Centre and cross-
referenced with the Directory of Critical Care 2006 (CMA
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Medical Data, Loughborough). The questionnaire and cover-
ing letter was addressed to the 'Clinical Director' of the ICU,
and a stamped self-addressed return envelope was provided.
The local ethics committee (Royal Berkshire NHS Foundation
Trust, Reading, UK) was approached, but formal processing
and approval was deemed unnecessary.
The questionnaire was posted out in November 2006. Those
ICUs that did not reply received follow-up questionnaires in
December 2006 and March 2007. The last response was
received in June 2007.
The data were entered into a database (Microsoft Excel Office
2003; Microsoft Corp., Redmond, WA, USA). The data were
then read into version 9.1 of the SAS®1 system (SAS Institute
Inc., Cary, NC, USA) running under Microsoft Windows XP,
where they were summarized and analyzed. Data were cross-
tabulated as appropriate and Mantel-Haenszel χ2 tests were
used for analysis. Paired t-tests were used to look for any dif-
ferences for cost versus duration of action. Differences were
deemed to be statistically significant at P < 0.05.
Results
A total of 302 UK ICUs were identified and responses were
received from 192 (63.5%). Seven of these responses were
excluded from further analysis; five were high dependency
units that do not admit ventilated patients, and two question-
naires were returned blank. The denominator used for the
results and statistical analysis was 185. The geographical dis-
tribution revealed that 155 hospitals were situated in England,
15 in Scotland, 10 in Wales and five in Northern Ireland. The
demographic data of the replying ICUs are outlined in Table 1
and reveal that a wide range of ICUs were surveyed.
Table 2 illustrates that 88.1% of UK ICUs utilize a sedation
scoring tool. The Ramsey Sedation Scale score [23] is the
most widely used (66.5%). A number of ICUs have developed
their own sedation scores (details unknown), and have named
them after their place of development/workplace.
Most UK ICUs (80%) have a written sedation guideline and
78% practice daily sedation holding. However, only 53% of
ICUs audit compliance with their guidelines (Table 2). No dif-
ference could be observed between units of different size or
depending on number of admissions (Table 3).
Neuromuscular blocking agents are infrequently used, with
71% of ICUs using it less than 5% of the time. However, 7%
of ICUs use muscular blocking agents in more than 10% of
their patients; these ICUs were predominantly neurosurgical
(Table 4).
According to visual-analogue scale assessment (0 = not
affecting decision and 10 = main factor), choice of sedating
agent is strongly influenced by duration of action. In compari-
son, cost of the sedating drug has less of an influence on
sedation choice (mean visual-analogue scale score cost 4.4
versus duration of action 6.4; P < 0.0001; Figure 1).
A range of sedating agents are used by the surveyed ICUs
(Table 5). Propofol is the most frequently used sedating agent
for patients with expected duration of ICU admission less than
24 hours. For an expected ICU admission of more than 24
hours, midazolam and propofol are the most commonly used
agents. During ventilator weaning, propofol is used most fre-
quently, with clonidine being the next most commonly used
agent.
Table 1
General Data
Variable Number of units (%)
Number of beds
0 to 4 26 (14%)
5 to 8 99 (53%)
9 to 12 36 (19%)
>12 24 (13%)
Total: 185 units
Number of ICU admissions/yeara
<250 17 (9%)
250 to 500 83 (45%)
500 to 750 43 (23%)
750 to 1,000 22 (12%)
>1,000 17 (9%)
Total: 182 units
% ventilated patientsa
0 to 25 7 (4%)
26 to 50 45 (24%)
51 to 75 79 (43%)
76 to 100 49 (26%)
Total: 180 units
Type of patientsb
Surgical 157 (85%)
Medical 156 (84%)
Cardiac 13 (7%)
Neurological 21 (11%)
aNo answer to the question was given by some units. bMore than one 
type of patient in an ICU was possible. ICU, intensive care unitAvailable online http://ccforum.com/content/12/6/R152
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A wider range of analgesic agents is used during the sedation
of ICU patients. For short-term analgesia, alfentanil, morphine,
fentanyl and remifentanil are commonly used. For longer
expected sedation (>24 hours), morphine is the most com-
monly used agent.
Discussion
Sedation scoring
The majority of responding ICUs (88%) in our survey use a
sedation scoring system. This has increased considerably
since the UK survey in 2000, when 67% of hospitals used a
scoring system [22]. Despite this increased uptake since the
Table 2
Sedation scoring practice
Question Number of units (%)
Do you use a sedation score?
Yes 163 (88.1%)
No 19
Which sedation score do you use? (several answers possible)
Ramsey Sedation Scale 123 (66.5%)
Richmond Agitation Sedation scale 10 (5.4%)
Bispectral Index 4 (2.1%)
Score of the UK Intensive Care Society 7 (3.8%)
Sheffield 4 (2.2%)
Bloomsbury 2 (1.1%)
Cambridge 2 (1.1%)
Cook 3 (1.6%)
Local scoring system, unspecified 3 (1.6%)
Other, but not specified 7 (3.8%)
No answer given 3 (1.6%)
Do you have a sedation guideline?
Yes 148 (80%)
No 37
Do you practice daily sedation holding?
Yes 144 (77.8%)
No 41
Do you audit your compliance with your sedation holding guideline?
Yes 99 (53.5%)
No 82
If you audit your compliance with your sedation holding practice, what is your compliance?
0% to 40% 5
40% to 60% 14
60% to 80% 26
80% to 90% 23
90% to 100% 24
The sum of answers is less than 185 in some cases as no answer to the question was given by some units.Critical Care    Vol 12 No 6    Reschreiter et al.
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last survey and favourable comparison with other countries, an
evidence-based approach is still not universally followed.
Numerous sedation assessment tools have been developed to
minimize this risk for over-sedation. Some sedation scales
have been validated against other scales in patients (for exam-
ple, Riker Sedation-Agitation Scale [24,25], Motor Activity
Assessment Scale [26], Vancouver Interaction and Calmness
Scale [27], and more recently the Richmond Agitation-Seda-
tion Scale [28,29], published after the American College of
Critical Care Medicine (ACCM) guidelines [12]. The latter has
shown an excellent performance, not only with regard to inter-
rater reliability and validity, but it is also the first score to detect
changes over time in the critically ill patient. However, no con-
sensus yet exists in an international guideline regarding which
assessment tool to use, and validation itself is problematic
because of the lack of a standard to validate against that is not
based on opinion.
The uptake of the Richmond Agitation-Sedation Scale has
been slow in previous surveys. It did not feature in the 2005
German survey [17] or in the Canadian survey conducted in
2006 [18], with one unit reporting its use in the 2007 German
update survey. The French survey in 2007 [21] and our study
are the first reports of its use being more widespread.
The sedation scale used most commonly in this survey was the
Ramsey Sedation Scale [23], with 66.5% of ICUs using this
sedation assessment. Furthermore, most of the other scales
used are adaptations of the Ramsay Sedation Scale (for exam-
ple, the UK Intensive Care Society sedation scale). The choice
of sedation scoring tool has not changed since the last UK sur-
vey, with the Ramsay Sedation Scale score being used most
commonly then (40 out of 142 units stating that they used a
sedation scoring system in 2000) [22].
The widespread use of the Ramsay Sedation Scale is in con-
trast to the ACCM guidelines [12], which recommend use of
the validated assessment scores, such as the Motor Activity
Assessment Scale, Riker Sedation-Agitation Scale, and Van-
couver Interaction and Calmness Scale. Its advantages
appear to be familiarity to staff and simplicity, and it is the scale
that has been most commonly used historically despite its clin-
ical limitations. However, the Ramsay Sedation Scale lacks
clear discrimination and exhibits considerable inter-rater varia-
bility [30].
The practice of sedation assessment in the UK differs from
that in other countries. In Germany in 2005 only 51% of
responding ICUs report sedation monitoring, with the Ramsay
Sedation Scale used 'almost exclusively'[17], and in Canada
in 2006 only 49% of responding ICUs utilized sedation moni-
toring, with 69% of ICUs using the Ramsay Sedation Scale
[17,18,20]. Our results are consistent with a 2001 sedation
survey conducted in European ICUs [28], which showed that
ICUs in the UK use sedation scales more frequently than do
Table 3
Size of unit and sedation practice
Number of beds Number of ICUs 
(n = 185)
Sedation guideline (n = 
148)#
No guideline (n = 37) Daily sedation holding 
(n = 144)
No sedation holding 
(n = 41)
0 to 4 26 19 (73%) 7 (27%) 20 (77%) 6 (23%)
5 to 8 99 78 (79%) 21 (21%) 78 (79%) 21 (21%)
9 to 12 36 30 (83%) 6 (17%) 31 (86%) 5 (14%)
>12 24 20 (83%) 3 (13%) 15 (63%) 9 (37%)
Percentages are out of the ICUs of that size group. No statistically significant differences were observed. # One ICU with more than 12 beds left 
this question unanswered. ICU, intensive care unit.
Table 4
Neuromuscular blocking agents used
% of patients Number of ICUs Number of neurological ICUs
0% to 5% 128 (71%) 4 neurological ICUs
6% to 10% 39 (22%) 7 neurological ICUs
11% to 15% 6 (3%) 2 neurological ICUs
16% to 20% 6 (3%) 5 neurological ICUs
>20% 2 (1%) 1 neurological ICU, one cardiac-ICU
The denominator was 181 (four responding ICUs did not answer this question). ICU, intensive care unit.Available online http://ccforum.com/content/12/6/R152
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those in all other participating European countries (72% of UK
ICUs).
Sedation guidelines
It has been shown in many but not all studies over the past
decade that an ICU sedation protocol results in fewer days on
the ventilator, a shorter stay in the ICU and reduced costs [31-
37]. Despite the mostly good evidence and a comparably easy
and cheap means of improving care, not all hospitals have
implemented a formal sedation guideline.
In this survey, 80% of the responding hospitals have an oper-
ating sedation guideline, which has increased sharply since
2000, when 43% of participating hospitals stated that they
had a written guideline. A German survey conducted in 2007
[20] revealed that 46% of hospitals used a sedation guideline,
and the Canadian survey in 2006 [18] reported that 29% of
ICUs used a sedation protocol.
Our high rate of ICUs reporting use of a sedation guideline
could reflect reporter bias, because units with more interest in
sedation may be more likely to respond to this questionnaire.
However, there has been increased utilization of sedation
guidelines in Germany in the recent years, suggesting that our
results may reflect actual change in practice [20].
Sedation holding
In 2000, Kress and coworkers [7,11] showed that daily with-
holding of sedative agents led to reduced length of ICU stay,
less ventilator time, fewer ICU complications and fewer neuro-
logical investigations. Subsequent studies by the same group
demonstrated daily sedation withholding to be safe in patients
with ischaemic heart disease, and that it reduces the psycho-
logical sequelae of critical illness [10,38]. A different group,
however, raised safety concerns in a trial including a high per-
centage of patients (around 30% to 40%) with alcohol and
other drug use disorders, emphasizing that patient selection
and an individualized approach is important [39].
A recent pilot trial addressed the issue of safety and feasibility
of daily interruption of sedation with simultaneous use of pro-
tocolized sedation [40]. The authors concluded that in their
Figure 1
Importance of cost and duration of action on choice of agent Importance of cost and duration of action on choice of agent. A 
total of 185 units are included in this analysis. VAS, visual analogue 
scale (range: 0 = not important to 10 = most important).
Table 5
Agents used stratified by expected length of stay in the ICU
Expected length of stay in the ICU <24 hours >24 hours Weaning
For sedation
Propofol 181 111 65
Midazolam 23 136 8
Clonidine 2 20 22
Lorazepam 2 13 3
H a l o p e r i d o l 157
D i a z e p a m 121
For analgesia
Morphine 51 125 14
Fentanyl 45 46 16
Alfentanil 96 67 24
Remifentanil 43 11 24
K e t a m i n e 130
Multiple answers were possible. Values are numbers of units. A total of 185 units are included in this analysis. ICU, intensive care unit.Critical Care    Vol 12 No 6    Reschreiter et al.
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pilot daily trial sedation practice was not associated with an
increased incidence of adverse events.
Sedation withholding is now part of the 'ventilator care bun-
dle', as outlined by the UK Department of Health [33], and rec-
ommended by the Surviving Sepsis Campaign [41].
In our survey, 78% of the ICUs state that they practice daily
sedation holding. By comparison, the reported proportion of
ICUs practicing sedation withholding in Canada is 40%, in
Denmark it is 31% and in Germany it is 34% [18-20]. How-
ever, our study revealed that only 53% of ICUs audit their use
of daily sedation holding, which suggests that the number of
ICUs practicing sedation holding effectively is probably lower
than the 78% stated.
There may be many reasons why ICUs are not practicing daily
sedation holding. Devlin and coworkers [42] surveyed Ameri-
can clinicians in 2004 and found that some ICUs were not
adopting sedation holding because of a lack of nursing
acceptance of this practice, a potential increase in patient self-
harm, potential for respiratory compromise and concern about
patient comfort.
The high rates of sedation holding reported in this study may
reflect increasing awareness and acceptance of the technique
and most subsequent studies supporting its safety and bene-
fit.
Choice of agents used
The sedation guideline published by the ACCM [12] recom-
mends use of fentanyl or morphine for analgesia, midazolam or
propofol for short-term sedation, and lorazepam for longer
term sedation. The practice in the UK differs greatly from these
guidelines. Alfentanil is used more commonly than fentanyl or
morphine, likely because of its lesser degree of accumulation
and shorter duration of action. For patients expected to require
sedation for longer than 24 hours, morphine and midazolam
were most frequently chosen, whereas lorazepam is rarely
chosen.
Our survey illustrated that the duration of action of the sedat-
ing agent was a more important factor in choice of sedating
agent than its cost. This concurs with the German sedation
survey [20]. It will be interesting to observe whether newer
short-acting but more expensive agents (for instance, remifen-
tanil and dexmedetomidine) are chosen for sedation in the
future.
Neuromuscular blocking agents
Muscle relaxing agents are infrequently used in UK ICUs. The
few ICUs using neuromuscular blocking agents (NMBAs) in
more than 10% of patients were mostly neurological ICUs. The
infrequent use of NMBAs may reflect the increasing emphasis
on lighter levels of sedation and the concerns regarding criti-
cal illness neuropathy and myopathy [43].
Study limitations
This study shares the limitations of all surveys in that reporter
bias cannot be excluded. Furthermore, only the head of the
department was addressed; the answers may therefore only
reflect the individual's practice, and may not be representative
for the entire unit. Past surveys, however, would have faced
similar limitations, and given our good response rate, compar-
ison with surveys in the past and in other countries can be
made. The wide range of units responding make it likely that
our results reflect actual UK practice appropriately, within the
constraints of self-reporting practice.
Conclusion
An increasing number of ICUs in the UK utilize a sedation
guideline and a sedation scoring tool. The Ramsey Sedation
Scale is the most frequently chosen assessment score. Seda-
tion holding is done by most but not all of the ICUs. Its imple-
mentation compares favourable with that identified in other
international sedation surveys. The choice of sedating agent is
quite variable and differs from that in other countries. Choice
of sedating agent is directed more by duration of action rather
by cost. NMBAs are infrequently used outside neurological
ICUs.
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Key messages
￿  The majority of units have a standardized approach to 
sedation management, using a sedation guideline, 
sedation scoring and daily sedation holding.
￿  In contrast to published guidelines and existing evi-
dence, there is still a considerable number of ICUs that 
do not practice effective daily sedation holding.
￿  Wide variation exists in the choice of sedating or anal-
gesic agent, with the short-acting opioid alfentanil being 
a popular choice.
￿  Only a minority of ICUs use NMBAs regularly.
￿  Choice of sedating agent is directed more by duration 
of action rather by cost.Available online http://ccforum.com/content/12/6/R152
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